Literature DB >> 19419269

Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.

Erik R Dubberke1, Anne M Butler, Bala Hota, Yosef M Khan, Julie E Mangino, Jeanmarie Mayer, Kyle J Popovich, Kurt B Stevenson, Deborah S Yokoe, L Clifford McDonald, John Jernigan, Victoria J Fraser.   

Abstract

OBJECTIVE: To evaluate the impact of cases of community-onset, healthcare facility (HCF)-associated Clostridium difficile infection (CDI) on the incidence and outbreak detection of CDI.
DESIGN: A retrospective multicenter cohort study.
SETTING: Five university-affiliated, acute care HCFs in the United States.
METHODS: We collected data (including results of C. difficile toxin assays of stool samples) on all of the adult patients admitted to the 5 hospitals during the period from July 1, 2000, through June 30, 2006. CDI cases were classified as HCF-onset if they were diagnosed more than 48 hours after admission or as community-onset, HCF-associated if they were diagnosed within 48 hours after admission and if the patient had recently been discharged from the HCF. Four surveillance definitions were compared: cases of HCF-onset CDI only (hereafter referred to as HCF-onset CDI) and cases of HCF-onset and community-onset, HCF-associated CDI diagnosed within 30, 60, and 90 days after the last discharge from the study hospital (hereafter referred to as 30-day, 60-day, and 90-day CDI, respectively). Monthly CDI rates were compared. Control charts were used to identify potential CDI outbreaks.
RESULTS: The rate of 30-day CDI was significantly higher than the rate of HCF-onset CDI at 2 HCFs (P < .01). The rates of 30-day CDI were not statistically significantly different from the rates of 60-day or 90-day CDI at any HCF. The correlations between each HCF's monthly rates of HCF-onset CDI and 30-day CDI were almost perfect (rho range, 0.94-0.99; P < .001). Overall, 12 time points had a CDI rate that was more than 3 standard deviations above the mean, including 11 time points identified using the definition for HCF-onset CDI and 9 time points identified using the definition for 30-day CDI, with discordant results at 4 time points ((kappa = 0.794; P < .001).
CONCLUSIONS: Tracking cases of both community-onset and HCF-onset, HCF-associated CDI captures significantly more CDI cases, but surveillance of HCF-onset, HCF-associated CDI alone is sufficient to detect an outbreak.

Entities:  

Mesh:

Year:  2009        PMID: 19419269      PMCID: PMC4156290          DOI: 10.1086/597380

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  16 in total

1.  Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.

Authors:  Tara N Palmore; SeJean Sohn; Sharp F Malak; Janet Eagan; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2005-08       Impact factor: 3.254

2.  Statistical quality control methods in infection control and hospital epidemiology, Part II: Chart use, statistical properties, and research issues.

Authors:  J C Benneyan
Journal:  Infect Control Hosp Epidemiol       Date:  1998-04       Impact factor: 3.254

Review 3.  Clostridium difficile--associated diarrhea.

Authors:  S Johnson; D N Gerding
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

Review 4.  Statistical quality control methods in infection control and hospital epidemiology, part I: Introduction and basic theory.

Authors:  J C Benneyan
Journal:  Infect Control Hosp Epidemiol       Date:  1998-03       Impact factor: 3.254

5.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

6.  The use of statistical process control charts in hospital epidemiology.

Authors:  J A Sellick
Journal:  Infect Control Hosp Epidemiol       Date:  1993-11       Impact factor: 3.254

7.  Recommendations for surveillance of Clostridium difficile-associated disease.

Authors:  L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-25       Impact factor: 3.254

8.  Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-12-02       Impact factor: 17.586

9.  Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?

Authors:  Erik R Dubberke; Kathleen M McMullen; Jennie L Mayfield; Kimberly A Reske; Peter Georgantopoulos; David K Warren; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

10.  Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.

Authors:  Erik R Dubberke; Kimberly A Reske; Margaret A Olsen; Kathleen M McMullen; Jennie L Mayfield; L Clifford McDonald; Victoria J Fraser
Journal:  Arch Intern Med       Date:  2007-05-28
View more
  12 in total

1.  Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities.

Authors:  Erik R Dubberke; Humaa A Nyazee; Deborah S Yokoe; Jeanmarie Mayer; Kurt B Stevenson; Julie E Mangino; Yosef M Khan; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2012-01-19       Impact factor: 3.254

2.  A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006.

Authors:  Amelia M Kasper; Humaa A Nyazee; Deborah S Yokoe; Jeanmarie Mayer; Julie E Mangino; Yosef M Khan; Bala Hota; Victoria J Fraser; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2012-03-20       Impact factor: 3.254

3.  Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates.

Authors:  Rebekah W Moehring; Eric T Lofgren; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2013-08-29       Impact factor: 3.254

4.  Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains.

Authors:  Vladimir Beran; Dittmar Chmelar; Jana Vobejdova; Adela Konigova; Jakub Nemec; Josef Tvrdik
Journal:  Folia Microbiol (Praha)       Date:  2013-10-11       Impact factor: 2.099

5.  The epidemiology of community-acquired Clostridium difficile infection: a population-based study.

Authors:  Sahil Khanna; Darrell S Pardi; Scott L Aronson; Patricia P Kammer; Robert Orenstein; Jennifer L St Sauver; W Scott Harmsen; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

6.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

Review 7.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 8.  The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.

Authors:  E R Dubberke; D B Haslam; C Lanzas; L D Bobo; C-A D Burnham; Y T Gröhn; P I Tarr
Journal:  Zoonoses Public Health       Date:  2010-09-24       Impact factor: 2.702

9.  Outcomes in community-acquired Clostridium difficile infection.

Authors:  S Khanna; D S Pardi; S L Aronson; P P Kammer; L M Baddour
Journal:  Aliment Pharmacol Ther       Date:  2012-01-10       Impact factor: 8.171

10.  Multicenter study of Clostridium difficile infection rates from 2000 to 2006.

Authors:  Erik R Dubberke; Anne M Butler; Deborah S Yokoe; Jeanmarie Mayer; Bala Hota; Julie E Mangino; Yosef M Khan; Kyle J Popovich; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.